Editor-in-Chief’s welcome to Hepatology, Medicine and Policy
Tóm tắt
Hepatology, Medicine and Policy (HMAP), a new open-access peer-reviewed journal, is making its debut at a time when the hepatitis field is seeing great progress but still has far to go. The World Health Organization and many countries have shown increasing interest in viral hepatitis in recent years, helping to foster a stronger response to this group of diseases. Meanwhile, alcohol-associated cirrhosis and alcohol-associated liver cancer continue to take a heavy toll worldwide, as does non-alcoholic fatty liver disease. The lack of a unified strategic response to viral hepatitis and other liver diseases is the impetus for launching HMAP, which will publish policy, public health and social science articles alongside clinical science articles. It will encourage submissions in diverse domains such as disease prevention and management, epidemiology, economics, health behavior, health service delivery, ethics, human rights, and the role of laws, policies and clinical guidelines in shaping health initiatives. The current attention to powerful new hepatitis C treatments presents a strategic opportunity to more comprehensively address the full constellation of biomedical and social issues relating to liver health. HMAP is committed to publishing research and policy articles that help to drive forward this broader agenda.
Tài liệu tham khảo
World Health Organization. Draft global health sector strategy on viral hepatitis, 2016–2021: the first of its kind (draft 13.11.2015). 2015. http://www.who.int/hepatitis/strategy2016-2021/Draft_global_health_sector_strategy_viral_hepatitis_13nov.pdf?ua=1. Accessed 15 Mar 2016.
Sixty-Third World Health Assembly. WHA63.18 Hepatitis. 2010. http://apps.who.int/gb/ebwha/pdf_files/WHA63-REC1/WHA63_REC1-en.pdf.
Alcorn K. Building momentum, making the case: World Hepatitis Summit 2015 meeting report. 2015. http://worldhepatitisalliance.org/sites/default/files/resources/documents/World%20Hepatitis%20Summit%20Report.pdf. Accessed 15 Mar 2016.
World Hepatitis Alliance. Our members. 2015. http://worldhepatitisalliance.org/en/our-members. Accessed 15 Mar 2016.
Hepatitis C elimination in Europe: our vision for a hepatitis C-free Europe. 2016.http://www.hepatitis-c-initiative.eu/images/publications/hcv_elimination_manifesto_branded.pdf. Accessed 15 Mar 2016.
Glasgow declaration on viral hepatitis, 2015. http://www.worldhepatitisalliance.org/sites/default/files/resources/documents/WHS2015GlasgowDeclarationonViralHepatitis.pdf. Accessed 15 Mar 2016.
World Health Organization. Hepatitis A: fact sheet N. 328: updated July 2015. http://www.who.int/mediacentre/factsheets/fs328/en/. Accessed 15 March 2016.
World Health Organization: Hepatitis E: fact sheet N. 280: updated July 2015. http://www.who.int/mediacentre/factsheets/fs280/en/. Accessed 15 Mar 2016.
Pischke S, Wedemeyer H. Hepatitis E virus infection: multiple faces of an underestimated problem. J Hepatol. 2013;58:1045–6.
Sayed IM, Vercouter A-S, Abdelwahab SF, Vercauteren K, Meuleman P. Is hepatitis E virus an emerging problem in industrialized countries? Hepatology. 2015;62:1883–92.
GBD 2013, Mortality and Causes of Death Collaborators. Lancet. 2015;385:117–71.
Mishra A, Younossi ZM. Epidemiology and natural history of non-alcoholic fatty liver disease. J Clin Exp Hepatol. 2012;2:135–44.
Agrawal S, Duseja AK. Non-alcoholic fatty liver disease: east versus west. J Clin Exp Hepatol. 2015;2:122–34.
Hallsworth K, Avery L, Trenell MI. Targeting lifestyle behavior change in adults with NAFLD during a 20-min consultation: summary of the dietary and exercise literature. Curr Gastroenterol Rep. 2016;18:11.
On health. 2016. http://blogs.biomedcentral.com/on-health/. Accessed 15 Mar 2016.
Sixty-Seventh World Health Assembly. WHA67.6 Hepatitis. 2014. http://apps.who.int/gb/ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-en.pdf.